---
title: GBM196 GBM Model - TD2 Precision Oncology
description: Uncover Brain Cancer therapies' potential with GBM196 PDX, a key to drug development success.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/gbm196.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# GBM196 GBM Model
GBM196-derived PDX model is a crucial resource for investigating novel therapeutic strategies in Brain Cancer drug discovery. Researchers rely on GBM196 PDX to unlock the potential of promising therapies, accelerate drug development success, and improve patient outcomes. This model plays a central role in advancing the field of Brain Cancer treatment by providing a realistic platform for assessing treatment efficacy and safety.
## Model Details
**Cancer Location:** Intracranial
**Cancer Type:** Brain Cancer
**Model Name:** GBM196
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** Chemotherapy (Temozolomide)
**WES:** Yes
**Methylation:** Yes
**PDX Treatment:** Yes
**Patient Treatment History:** Yes
## GBM196 Survival
Survival of orthotopic intracranial implanted GBM196 in Nu/Nu mice (n=5)
### Request Additional GBM Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)